Trending...
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
AI.Reverie honored for achievements advancing computer vision with synthetic data
NEW YORK - ncarol.com -- CB Insights today named AI.Reverie, the leading synthetic data platform, to its annual AI 100 ranking of the most promising private artificial intelligence companies in the world for the second time.
"This year's cohort spans 18 industries, and is working on everything from climate risk to accelerating drug R&D," said CB Insights CEO Anand Sanwal. "Last year's AI 100 companies had a remarkable run after being named to the list, with more than 50% going on to raise additional financing (totaling $5.2B), including 16 $100 million+ mega-rounds. Many also went on to exit via M&A, SPAC or IPO. As industry after industry adopts AI, we expect this year's class will see similar levels of interest from investors, acquirers and customers."
"We are honored to be named to CB Insights' AI 100 List again," said AI.Reverie co-founder and CEO Daeil Kim. "Synthetic data is now a must-have, and more and more enterprises, government agencies and NGOs are tapping the AI.Reverie platform to accelerate AI development while protecting data privacy. The world-changing outcomes our customers achieve with our platform are the ultimate prize."
More on ncarol.com
Through an evidence-based approach, the CB Insights research team selected the AI 100 from a pool of over 6,000 companies based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty.
During 2020, AI.Reverie grew 3x as the demand for synthetic data to train vision algorithms spiked. Other milestones in the last year included:
About CB Insights
More on ncarol.com
CB Insights builds software that enables the world's best companies to discover, understand and make technology decisions with confidence. By marrying data, expert insights and work management tools, clients manage their end-to-end technology making process on CB Insights. To learn more, please visit www.cbinsights.com.
About AI.Reverie
The AI.Reverie synthetic data platform creates a virtually endless supply of annotated images and videos that accelerate computer vision and machine learning across domains. Its unique toolset preserves data privacy and provides the control to prevent bias in AI. Learn more at www.aireverie.com.
"This year's cohort spans 18 industries, and is working on everything from climate risk to accelerating drug R&D," said CB Insights CEO Anand Sanwal. "Last year's AI 100 companies had a remarkable run after being named to the list, with more than 50% going on to raise additional financing (totaling $5.2B), including 16 $100 million+ mega-rounds. Many also went on to exit via M&A, SPAC or IPO. As industry after industry adopts AI, we expect this year's class will see similar levels of interest from investors, acquirers and customers."
"We are honored to be named to CB Insights' AI 100 List again," said AI.Reverie co-founder and CEO Daeil Kim. "Synthetic data is now a must-have, and more and more enterprises, government agencies and NGOs are tapping the AI.Reverie platform to accelerate AI development while protecting data privacy. The world-changing outcomes our customers achieve with our platform are the ultimate prize."
More on ncarol.com
- Bettingbladet releases H1 2026 report on the Swedish online gambling market
- Garage door installation or repair in Minnesota? Which makes more sense for your family?
- Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
- Google AI Says KayeDinero Isn't the Greatest Female Producer. She Asks: Who Decides?
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
Through an evidence-based approach, the CB Insights research team selected the AI 100 from a pool of over 6,000 companies based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty.
During 2020, AI.Reverie grew 3x as the demand for synthetic data to train vision algorithms spiked. Other milestones in the last year included:
- An expansion of offerings into the Retail and Agriculture markets
- Inclusion in the United States Air Force's $3.3B, five-year Advance Battle Management System (ABMS) program
- A $1.5M AFWERX Phase 2 SBIR contract
- A $5.6M round of equity financing led by Vulcan
- The release of the largest open dataset of real and synthetic overhead imagery (Rareplanes, with the In-Q-Tel lab CosmiQ Works)
- Gartner recognition as a "Cool Vendor" in AI Core Technologies
- Forbes recognition as a "Top 25 Machine Learning Start-up," among other honors
About CB Insights
More on ncarol.com
- VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
- From Michael Jackson to Drake: The Artists Who Shaped KayeDinero's Sound
- L-Tron to Attend the 2026 NC, GA, TN, SC Joint Regional IAI Conference
- "Kulture Metrics" Isn't Just an Album Title: KayeDinero Connects Music, Markets and Code
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
CB Insights builds software that enables the world's best companies to discover, understand and make technology decisions with confidence. By marrying data, expert insights and work management tools, clients manage their end-to-end technology making process on CB Insights. To learn more, please visit www.cbinsights.com.
About AI.Reverie
The AI.Reverie synthetic data platform creates a virtually endless supply of annotated images and videos that accelerate computer vision and machine learning across domains. Its unique toolset preserves data privacy and provides the control to prevent bias in AI. Learn more at www.aireverie.com.
Source: AI.Reverie
0 Comments
Latest on ncarol.com
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
- DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
- Crawler Record for WordPress Version 1.0
- French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
- Piedmont Crossing Celebrates 40 Years of Caring, Community, and Connection
- LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
- ChatGPT Leans Mostly on Firms' Own Websites to Decide Which Environmental Consultant to Recommend
- What Does "Human Error" Sound Like North of Asheville? KayeDinero Brings New Era to Weaverville
- Before Asheville, There Was Cherokee: KayeDinero Reveals Where Her Carolina Chapter Really Began
- Profit at the Window: Free Webinar Helps Interior Designers Turn Window Treatments Into Revenue
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Local Ecomaids Owner Launches Healthy Home Reset Initiative for Triangle Families
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Asheville Artist KayeDinero Asks What Happens When Technology Gets Too Human on "Human Error"
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Mandeville Pests May Pose Serious Health Risks for Your Family
